2Q25 FINANCIAL RESULTS
August 7, 2025
Strategic execution for resilient and profitable growth
Şirkete Özel
Management Reporting: IFRS Financials excluding inflation accounting effect
Agesa maintained its leadership in both Pension AuM and Life & PA premium production among private companies thanks to significant growth across all channels and product lines.
Agesa's net profit grew significantly due to robust technical profits from all business lines
1H 2025 Performance
- #1 position in Private Pension AuM among private companies; 19.4% m.s.
- #1 position in Total Life & PA GWP among private companies; 13.3% m.s.
- Robust net profit growth both in terms of Management Reporting and SFRS with 73% and 86% yoy increase respectively
- 1.000 mTL dividend has been paid in Q1
Agesa has become the sole shareholder of Medisa with 100% share as of December 2024. Additional 650 mTL has been paid as capital in January 2025. Total investment amount is reached 1.4 bTL
- Share buyback program; 1.736k shares were bought with an average price of 65.58 TL as of June 2025. Ratio of owned share is 0.96%
Strengthened fundamentals
- Strong and exclusive bancassurance partnership with Akbank
- Accelerated growth with strengthened base of DSF
- More Diversified Product Portfolio with a New RoP and Savings Products
Continued investments on digital analytics and
customer capabilities- Synergies with Aksigorta both for topline and operational excellence areas
-
Regulatory appetite for the growth of both pension
and life business supported by incentives
- Strong Shareholder Structure that mixes local expertise and international know how
Future
End to end Digital transformation with a particular focus on new technologies and data analytics
Deepen collaboration with Akbank
Growth & synergy opportunities with Medisa in health business.
Sustainability at the heart of business to build a
better future
•
Future-proof workforce
organization and an advanced
2
Strong growth driven by diversified portfolio and unique distribution model
CAGR Inf. 21-24: 58%
YoY Inf. 1H25: 35%
robust growth with new participants and returns
Pension AuM, Total
(TL bn)
strong growth in terms of GWP with strong and diversified productsGWP, Total
(TL bn)
increased focus on pension, steady increase in # of customersCustomer exc. Credit Linked, #
(mn)
CAGR 21-24:
74%
YoY 1H25: 49%
CAGR 21-24:
92%
YoY 1H25: 64%
CAGR 21-24:
8%
YoY 1H25: 7%
Şirkete Özel
Management Reporting: IFRS Financials excluding inflation accounting effect. 3
Both Agesa Management reporting and SFRS financial figures are shown before Medisa consolidation.
Robust profitability fueled by solid and sustainable core business performance
CAGR Inf. 21-24: 58%
IFRS Net Profit
(Management Reporting, TL mn)
CAGR 21-24:
95%
YoY 1H25:
73%
QoQ:
16%
Local Net Profit
(TL mn)
CAGR 21-24:
86%
YoY 1H25:
86%
QoQ:
12%
YoY Inf. 1H25: 35%
Şirkete Özel
Management Reporting: IFRS Financials excluding inflation accounting effect.
Both Agesa Management reporting and SFRS financial figures are shown before Medisa consolidation.
4
Resilient net technical profitability with balanced product mix
CAGR Inf. 21-24: 58%
YoY Inf. 1H25: 35%
Technical Profit
(TL mn)
G&A, Expense Ratio
(TL mn, %)
Net Technical Profit
(TL mn)
CAGR 21-24:
87%
YoY 1H25: 76%
CAGR 21-24:
87%
YoY 1H25:
57%
CAGR 21-24:
86%
YoY 1H25:
101%
Şirkete Özel
Expense ratio=(G&A)/(Management Reporting Proft Before Tax-G&A) Management Reporting: IFRS Financials excluding inflation accounting effect.
Both Agesa Management reporting and SFRS financial figures are shown before Medisa consolidation. 5